Approval alone doesn’t guarantee commercial success. Robert Jordan shares how Vetirus Pharmaceuticals combines in-house regulatory expertise with early manufacturing planning, ensuring supply, shortening timelines to revenue, and enabling global expansion.

Can a global animal health company operate and navigate like a challenger? In this candid, two-way conversation, Laura and Kacey sit down to unpack what it actually takes to build and run a genuinely different kind of animal health business.

They'll dig into the dynamic between scale and agility, challenging some of the traditional assumptions about how large companies operate. What does it look like to focus resources where they truly move the needle and how do you design an organization that's easier for customers and partners to do business with.

Expect honest reflections on why the way a company chooses to operate can be just as important as what it brings to market, where the industry is heading next, along with practical takeaways for anyone rethinking how their own organization needs to evolve.

The US represents the world's largest and most dynamic animal health market, and we're seeing unprecedented investment and expansion from global leaders.

This panel will explore the strategic rationale behind these major moves: what makes the US market uniquely attractive, how global leaders navigate regulatory complexity and competitive dynamics, and what this wave of international investment signals about where the industry is heading.

Understanding outcomes and sharing that data up and down the value chain could be the single biggest accelerator of growth across the whole market in the years ahead. In this session Dottie will discuss how MVH are tackling the associated challenges and thinking about what this future could hold.

• The How: Developing an owner assessment of pet health and incorporating that into the medical record in a systematic and quantifiable way and combining this with the vet assessment
• The How: AI enabling the creation of valid and reliable tools
• Outcome: How can this data be used to de-risk investment in new biopharma, diagnostic, nutrition and tech solutions
• Outcome: Incorporating health outcomes data into your daily practice, from single clinics to large groups, the clinical patient management use case

Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 2 minutes for live Q&A from the judges panel.

Emerging companies can apply for the showcase:   Apply Now

Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 2 minutes for live Q&A from the judges panel.

Emerging companies can apply for the showcase:   Apply Now